- Home
- PRTA vs TRAK Comparison
PRTA vs TRAK Comparison
Compare PRTA & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- TRAK
- Stock Information
- Founded
- PRTA 2012
- TRAK 1990
- Country
- PRTA Ireland
- TRAK United States
- Employees
- PRTA N/A
- TRAK N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- TRAK EDP Services
- Sector
- PRTA Health Care
- TRAK Technology
- Exchange
- PRTA Nasdaq
- TRAK Nasdaq
- Market Cap
- PRTA 346.4M
- TRAK 374.5M
- IPO Year
- PRTA N/A
- TRAK 1998
- Fundamental
- Price
- PRTA $6.29
- TRAK $18.47
- Analyst Decision
- PRTA Buy
- TRAK
- Analyst Count
- PRTA 9
- TRAK 0
- Target Price
- PRTA $27.67
- TRAK N/A
- AVG Volume (30 Days)
- PRTA 1.3M
- TRAK 69.2K
- Earning Date
- PRTA 08-07-2025
- TRAK 05-15-2025
- Dividend Yield
- PRTA N/A
- TRAK 0.39%
- EPS Growth
- PRTA N/A
- TRAK 21.41
- EPS
- PRTA N/A
- TRAK 0.34
- Revenue
- PRTA $137,935,000.00
- TRAK $22,028,373.00
- Revenue This Year
- PRTA N/A
- TRAK $15.18
- Revenue Next Year
- PRTA $122.02
- TRAK $10.00
- P/E Ratio
- PRTA N/A
- TRAK $55.01
- Revenue Growth
- PRTA 54.55
- TRAK 9.73
- 52 Week Low
- PRTA $4.32
- TRAK $15.72
- 52 Week High
- PRTA $25.42
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- PRTA 56.80
- TRAK 38.89
- Support Level
- PRTA $6.16
- TRAK $18.19
- Resistance Level
- PRTA $6.60
- TRAK $19.50
- Average True Range (ATR)
- PRTA 0.27
- TRAK 0.58
- MACD
- PRTA 0.04
- TRAK -0.03
- Stochastic Oscillator
- PRTA 67.90
- TRAK 33.83
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.